Published On: Thu, May 27th, 2021

Divi’s Laboratories to manufacture API of MSD’s Covid drug Molnupiravir

Tagged with: | | | | | |

Divi’s Laboratories Limited has been selected by pharma giant MSD (known as in the US and ) as an authorized manufacturer for the active pharmaceutical ingredient (API) of the latter drug candidate .

The Hyderabad-based API producer said that it is allowed to supply Molnupiravir API to MSD’s

Currently, Molnupiravir is being evaluated in a phase 3 clinical trial. MSD is developing the drug candidate in collaboration with Ridgeback Biotherapeutics.

Divi's Laboratories to manufacture API of MSD’s Covid drug Molnupiravir

Divi’s Laboratories to manufacture API of MSD’s Covid drug Molnupiravir. Image courtesy of Pete Linforth from Pixabay.

Last month, Cipla signed a non-exclusive licensing agreement with MSD for the manufacturing and distribution of Molnupiravir for the treatment of non-hospitalized Covid-19 .

Related posts

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>